
Dienogest vs. Combined Oral Contraceptives for Endometriosis Pain: What a 2025 Meta-Analysis Found
Which is better depends on your pain type: how dienogest and OCPs compare, plus quality-of-life and side-effect trade-offs.

Living with endometriosis can mean living with pain that affects your body, your energy, your relationships, and your daily plans. Two commonly used hormonal medication options are dienogest (a progestin) and combined oral contraceptive pills (OCPs). A 2025 systematic review and meta-analysis in BMC Women’s Health compared the short-term effects of these treatments on pain, quality of life, and side effects in women with endometriosis.
Below is a patient-friendly breakdown of what the researchers found—and how you can use this information in a conversation with your clinician.
Why compare dienogest and OCPs?
Both dienogest and oral contraceptive pills (OCPs) are commonly used to help manage endometriosis symptoms, and patients often want to understand how they compare in practical terms. Key questions typically focus on which option is more effective for reducing pain, which leads to greater improvements in overall quality of life, and whether the side-effect profiles differ in meaningful ways that might influence treatment choice. This study aimed to compare them head-to-head using results from randomized controlled trials (RCTs).
What type of study is this—and why that matters
This paper is a systematic review and meta-analysis of randomized controlled trials(RCTs), conducted using PRISMA guidelines. That means the authors:
- Systematically searched for relevant RCTs
- Combined results across trials to estimate overall effects
Important note: the findings apply to short-term outcomes. The authors specifically note that long-term data (like recurrence rates or bone-related outcomes) were limited.
Key results: pain relief depends on the type of pain you have
Endometriosis pain isn’t one single experience. The review suggests the “best” option may depend on which pain symptom is most disruptive for you.
Dienogest may help more with “generalized pain” (overall pain on a VAS scale)
Across studies, dienogest showed greater improvement in overall/general pain, measured with a VAS (Visual Analog Scale), compared with OCPs. The meta-analysis reported a statistically significant improvement favoring dienogest (P = 0.001; SMD = −1.46; 95% CI −2.33 to −0.59).
What this could mean for you: If your biggest issue is broad, general endometriosis pain (for example, pain that isn’t only limited to deep pelvic pain or intercourse), dienogest may be a strong option to discuss.
OCPs may help more with pelvic pain and pain during sex (dyspareunia)
The review found dienogest was less effective than OCPs for:
- Pelvic pain (P = 0.009; SMD = 0.42)
- Dyspareunia (pain during intercourse) (P = 0.006; SMD = 0.70)
What this could mean for you: If your main symptoms are pelvic painor pain with intercourse, OCPs may offer more relief—based on these short-term RCT findings.
Quality of life: physical and daily-life areas may improve more with dienogest
Quality of life was measured using tools such as EHP-5, EHP-30, and SF-12.
Where dienogest may have an advantage
Compared with OCPs, dienogest significantly improved:
- EHP-5
- EHP-30
- SF-12 Physical Component Summary (PCS)
These measures can reflect how symptoms affect daily functioning (like activity and physical well-being), depending on the questionnaire domain.
Struggling with Endometriosis Pain?
Our specialists are here to help you understand your condition and explore your treatment options.
Schedule Your ConsultWhere there was no clear difference
There was no significant difference between dienogest and OCPs for:
- SF-12 Mental Component Summary (MCS)
- WHO-QoL scores
What this could mean for you: Dienogest may improve some physical and endometriosis-specific quality-of-life measures more than OCPs, but this meta-analysis did not show a clear short-term difference in overall mental health domains between treatments.
Side effects: mostly similar, but two differences stood out
The review reported no significant difference between dienogest and OCPs in the risk of:
- Vaginal bleeding
- Headache
- Hot flashes
- Back pain
- Skin dryness
- Nausea
However, OCPs were associated with higher risk of:
- Weight gain
- Hand numbness
What this could mean for you: If weight change is a major concern for you, or if you have experienced tingling/numbness symptoms before, it may be worth raising these points when discussing OCPs.
Practical takeaways: how to use this evidence in your treatment decision
Because the study suggests benefits differ by symptom type, a “one-size-fits-all” answer isn’t realistic. Consider bringing these questions to your next appointment:
1) “Which pain symptom are we targeting most?”
- More generalized/overall pain → ask about dienogest
- More pelvic pain or dyspareunia → ask about OCPs
2) “How will we track if the medication is working?”
Ask what you’ll monitor over the next weeks/months—pain scores, bleeding patterns, daily functioning, or specific quality-of-life measures.
3) “What side effects should make me contact you?”
Since most side effects were similar, it’s still important to have a plan for what to do if you experience bleeding changes, headaches, or other symptoms. Also ask specifically about:
- Weight changes
- Numbness/tingling in the hands
What this study cannot tell us (important limitations)
This paper focuses on short-term outcomes. The authors note key gaps, including:
- Limited evidence on long-term effectiveness
- Lack of long-term data on outcomes such as recurrence and bone-related changes
- Differences among the types of OCPs used across trials (meaning not all “OCPs” are identical)
If you’re making a long-term plan, you and your clinician may need additional evidence and ongoing follow-up to decide what fits best.
Bottom line
- Surgery diagnosis and treatment in these studies: All significant studies reviewed in this analysis noted that endometriosis was biopsy proven but surgery was remote in many (>5 years) and thus synergies with surgical excision were not addressed in this comparison.
- Dienogest may be better for overall/general endometriosis pain and may improve some physical/endometriosis-specific quality-of-life measures more than OCPs in the short term.
- OCPs may work better for pelvic pain and pain during intercourse (dyspareunia).
- Side effects were mostly similar, but OCPs showed higher risk of weight gain and hand numbness in this analysis.
- The best choice often depends on your main pain pattern, quality-of-life priorities, and side effect concerns—and should be revisited over time.
References
Xie J, Ni X, Huang Q, Guo Y. Relugolix’s impact on endometriosis-associated pain and quality of life: a meta-analysis of EHP-30 outcomes. Frontiers in Endocrinology. 2025. (Systematic review and meta-analysis of RCTs; PRISMA-guided.) DOI: 10.3389/fendo.2025.1650579
Quick Answers
Can endometriosis cause arthritis-like joint pain?
Yes—endometriosis can be associated with arthritis-like joint pain in some people, even though joint pain isn’t considered a classic “core” symptom. Endometriosis can drive chronic inflammation and immune dysregulation, and that whole-body inflammatory state may show up as aching, stiffness, or flares that feel similar to inflammatory arthritis. Some patients also notice joint symptoms that cycle with their period or worsen during broader endometriosis flares.
At the same time, endometriosis doesn’t “equal” autoimmune arthritis, and an association doesn’t prove that one causes the other. Research suggests higher rates of certain autoimmune conditions in people with endometriosis—including inflammatory diseases that can affect joints—so persistent joint pain deserves a full-picture evaluation rather than being automatically attributed to pelvic disease alone. If you’re dealing with pelvic pain plus joint symptoms, our team can help you sort out what fits endometriosis, what may be a related immune condition, and how that affects your treatment plan, including whether excision surgery and coordinated integrative support make sense for you.
How long do endometriosis flare-ups last?
Endometriosis flare-ups don’t have one “usual” length—some people feel a spike in symptoms for a few hours to a couple of days, while others have flares that stretch across an entire cycle window or blend into more constant pain. Many flares track with hormonal shifts (often before and during a period), but bowel, bladder, pelvic floor, or nerve-related pain can flare at different times and may not follow a neat calendar pattern.
When flares start lasting longer or happening more often, it can be a sign that multiple pain drivers are stacking—ongoing inflammation from lesions, adhesions/fibrosis that can “tether” organs, and sometimes central sensitization, where the nervous system becomes more reactive over time. That’s why symptom management alone can feel like a band-aid if active disease is still present. If you’re noticing prolonged, unpredictable, or escalating flares, our team can help you map your pattern, identify what’s likely driving it, and discuss a plan that addresses both symptom control and the underlying endometriosis.
Can I fly with a large endometrioma?
Yes—many people can fly with an endometrioma, even a large one, but “safe” depends on your individual risk profile and symptoms. The main in-flight concern with a larger ovarian cyst is an acute complication like torsion (the ovary twisting) or, less commonly, rupture—events that can happen on any day, but feel especially stressful when you’re far from care. Cabin pressure changes aren’t known to make endometriomas expand, but dehydration, constipation, prolonged sitting, and limited access to pain control can make a pelvic pain flare much harder to manage mid-flight.
If you’re having escalating one-sided pelvic pain, significant nausea/vomiting, fevers, dizziness/faintness, or pain that suddenly becomes severe, we generally want you evaluated before you travel—those can be warning signs that change the plan. If you do fly, think through logistics that reduce strain: choose an aisle seat if possible, plan for gentle movement and hydration, and have a clear pain plan for the travel day so you’re not improvising at 30,000 feet. If the endometrioma is growing, very symptomatic, or affecting fertility planning, our team can help you map next steps—whether that’s careful monitoring, symptom control while you travel, or discussing targeted treatment options designed to treat the disease rather than just chasing flares.
What is endo belly?
“Endo belly” is the common term patients use for the severe bloating and abdominal swelling that can happen with endometriosis. It’s often described as a belly that looks or feels suddenly distended—sometimes within hours—and may come and go in waves, frequently worsening around a period but not always. Importantly, this can mimic weight gain even when the underlying issue is swelling, fluid shifts, or gastrointestinal distension rather than true fat gain.
Endometriosis can irritate tissues in the pelvis and abdomen and can also affect (or “talk to”) the bowel, which helps explain why many people notice constipation, diarrhea, cramping, or a tight, pressured abdomen alongside pelvic pain. You can have significant digestive symptoms even when routine GI testing looks normal, because endometriosis often involves the outer surface or deeper layers around the bowel rather than the inner lining.
If endo belly is a major part of your symptom pattern—especially when it comes with painful bowel movements, cyclical flares, or persistent pelvic pain—our team can help you sort out what’s driving it and what treatment options are most likely to bring relief. Explore our educational resources, and if you’re ready, reach out to schedule a consultation so we can review your history and build a plan around your goals.
What are signs endometriosis has returned after surgery?
Endometriosis “returning” after surgery can show up as symptoms that improve for a while and then gradually (or suddenly) come back months or even years later. The most common signal is the return of your familiar pattern—cyclical pelvic pain, worsening period pain, pain with intercourse, or pain that starts spreading beyond where it used to be. Some people also notice bowel or bladder symptoms re-emerge (pain with bowel movements, rectal pressure, urinary urgency or bladder pain), especially if those organs were involved before. New or increasing fatigue and activity limitation can be part of the picture, but the key is a clear change from your post-op baseline.
It’s also important to know that recurrent pain doesn’t always equal recurrent disease. Even after complete excision, the nervous system can stay “turned up,” and pelvic floor dysfunction, adhesions, or central sensitization can keep pain going or make normal sensations feel painful—so we think in terms of patterns, triggers, and timing rather than a single pain score. If symptoms are returning, our team can help you sort whether you’re in a true recurrence lane (improved, then returned) versus persistent pain that never fully settled, and decide when imaging (such as ultrasound or MRI) is useful—particularly for tracking ovarian endometriomas. If you’re noticing a shift back toward your old symptoms, reach out to schedule a consultation so we can build a clear, long-term follow-up plan with you.

